Price loading...

MACMILLAN Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest

Price data last checked 107 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms. The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroboratingthe overemphasis on drug treatment in both research and practice. Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
11 December 2022
Listed Since
13 November 2022

Barcode

No barcode data available

Similar Products You Might Like

The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)
94% match

The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)

By

£50.73 07 Mar 2026
The Sedated Society: The Causes and Harms of our Psychiatric Drug Epidemic
93% match

The Sedated Society: The Causes and Harms of our Psychiatric Drug Epidemic

MACMILLAN

£46.51 07 Mar 2026
Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)
93% match

Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)

£66.90 02 Mar 2026
Neurobiology of Depression: Road to Novel Therapeutics
93% match

Neurobiology of Depression: Road to Novel Therapeutics

Academic Press

£101.89 11 Feb 2026
The Loss of Sadness: How psychiatry transformed normal sorrow into depressive disorder
93% match

The Loss of Sadness: How psychiatry transformed normal sorrow into depressive disorder

Oxford University Press

£34.71 16 Mar 2026
The Massachusetts General Hospital Guide to Depression: New Treatment Insights and Options (Current Clinical Psychiatry)
93% match

The Massachusetts General Hospital Guide to Depression: New Treatment Insights and Options (Current Clinical Psychiatry)

Humana

£94.25 09 Mar 2026
CRC Press Herbal Treatment of Major Depression - Science Book
93% match

CRC Press Herbal Treatment of Major Depression - Science Book

CRC Press

£95.67 04 Mar 2026
Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)
92% match

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Springer

£180.00 06 Jan 2026
Pharmacotherapy of Depression
92% match

Pharmacotherapy of Depression

Humana

£79.93 23 Feb 2026
Antidepressants Therapy & Risk of Suicide Among Patients with Major Depressive Disorders (Psychiatry - Theory, Applications and Treatments)
92% match

Antidepressants Therapy & Risk of Suicide Among Patients with Major Depressive Disorders (Psychiatry - Theory, Applications and Treatments)

£41.02 21 Feb 2026
Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)
92% match

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Springer

£294.92 12 Jan 2026
Ketamine for Treatment-Resistant Depression: The First Decade of Progress
92% match

Ketamine for Treatment-Resistant Depression: The First Decade of Progress

Adis

£64.63 08 Mar 2026
Drug Discovery for Psychiatric Disorders: Volume 28 (Drug Discovery Series)
92% match

Drug Discovery for Psychiatric Disorders: Volume 28 (Drug Discovery Series)

Royal Society of Chemistry

£70.03 09 Mar 2026
Deprescribing in Psychiatry
92% match

Deprescribing in Psychiatry

Oxford University Press

£44.01 09 Feb 2026
Depressive Disorders: Mechanisms, Measurement and Management: 1180 (Advances in Experimental Medicine and Biology, 1180)
92% match

Depressive Disorders: Mechanisms, Measurement and Management: 1180 (Advances in Experimental Medicine and Biology, 1180)

Springer

£75.01 23 Feb 2026
Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)
92% match

Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)

£252.99 13 Jan 2026
Treatments for Adolescent Depression: Theory and Practice
92% match

Treatments for Adolescent Depression: Theory and Practice

Oxford University Press

£38.40 23 Feb 2026
Managing Treatment-Resistant Depression: Road to Novel Therapeutics
92% match

Managing Treatment-Resistant Depression: Road to Novel Therapeutics

Academic Press

£155.56 25 Jan 2026
Treatment-Resistant Mood Disorders
92% match

Treatment-Resistant Mood Disorders

Cambridge University Press

£57.15 24 Feb 2026
Antidepressants (Milestones in Drug Therapy)
92% match

Antidepressants (Milestones in Drug Therapy)

Birkhauser

£63.53 20 Feb 2026
Springer Understanding Depression Vol 2 - Clinical Management
92% match

Springer Understanding Depression Vol 2 - Clinical Management

Springer

£116.90 19 Apr 2026
New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)
92% match

New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)

Springer

£134.41 24 Jan 2026
Springer - Ketamine: From Abused Drug to Rapid-Acting Antidepressant
92% match

Springer - Ketamine: From Abused Drug to Rapid-Acting Antidepressant

Springer

£114.72 14 Apr 2026
Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment
92% match

Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment

£61.49 08 Jan 2026